BORA PHARMACEUTICALS LTD - Asset Resilience Ratio

Latest as of March 2026: 0.04%

BORA PHARMACEUTICALS LTD (6472) has an Asset Resilience Ratio of 0.04% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 6472 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

NT$19.02 Million

≈ $599.08K USD Cash + Short-term Investments

Total Assets

NT$45.33 Billion

≈ $1.43 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how BORA PHARMACEUTICALS LTD's Asset Resilience Ratio has changed over time. See BORA PHARMACEUTICALS LTD (6472) net asset quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down BORA PHARMACEUTICALS LTD's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BORA PHARMACEUTICALS LTD (6472) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$19.02 Million	0.04%
Total Liquid Assets	NT$19.02 Million	0.04%

Asset Resilience Insights

Limited Liquidity: BORA PHARMACEUTICALS LTD maintains only 0.04% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

BORA PHARMACEUTICALS LTD Industry Peers by Asset Resilience Ratio

Compare BORA PHARMACEUTICALS LTD's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Huadong Medicine Co Ltd SHE:000963	Drug Manufacturers - Specialty & Generic	0.05%
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	Drug Manufacturers - Specialty & Generic	-0.89%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Fujian Cosunter Pharmaceutical Co Ltd SHE:300436	Drug Manufacturers - Specialty & Generic	-2.56%
Celltrion Pharm Inc KQ:068760	Drug Manufacturers - Specialty & Generic	12.49%
Hunan Warrant Pharmaceutical Co. Ltd. A SHG:688799	Drug Manufacturers - Specialty & Generic	0.40%

Annual Asset Resilience Ratio for BORA PHARMACEUTICALS LTD (2019–2025)

The table below shows the annual Asset Resilience Ratio data for BORA PHARMACEUTICALS LTD.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-09-30	0.05%	NT$21.55 Million ≈ $679.04K	NT$44.71 Billion ≈ $1.41 Billion	-0.15pp
2024-09-30	0.20%	NT$92.34 Million ≈ $2.91 Million	NT$45.60 Billion ≈ $1.44 Billion	-1.17pp
2023-09-30	1.37%	NT$342.63 Million ≈ $10.79 Million	NT$25.05 Billion ≈ $789.28 Million	+0.28pp
2022-09-30	1.09%	NT$247.63 Million ≈ $7.80 Million	NT$22.76 Billion ≈ $717.10 Million	+1.09pp
2021-09-30	0.00%	NT$78.00K ≈ $2.46K	NT$7.37 Billion ≈ $232.27 Million	+0.00pp
2020-09-30	0.00%	NT$64.00K ≈ $2.02K	NT$7.00 Billion ≈ $220.67 Million	-0.89pp
2019-09-30	0.89%	NT$30.00 Million ≈ $945.16K	NT$3.38 Billion ≈ $106.57 Million	--

pp = percentage points

About BORA PHARMACEUTICALS LTD

TW:6472 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$1.66 Billion

NT$52.54 Billion TWD

Market Cap Rank

#6985 Global

#216 in Taiwan

Share Price

NT$412.50

Change (1 day)

+1.73%

52-Week Range

NT$336.00 - NT$844.00

All Time High

NT$940.36